Erpolat, Ö. P. Et Al. 2014. Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: a national multi-center study.. European journal of gynaecological oncology , vol.35, no.1 , 62-6.

Erpolat, Ö. P., Alco, G., Caglar, H. B., Igdem, S., Saran, A., Dagoglu, N., ... Aslay, I.(2014). Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: a national multi-center study.. European journal of gynaecological oncology , vol.35, no.1, 62-6.

Erpolat, ÖZGE Et Al. "Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: a national multi-center study.," European journal of gynaecological oncology , vol.35, no.1, 62-6, 2014

Erpolat, ÖZGE P. Et Al. "Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: a national multi-center study.." European journal of gynaecological oncology , vol.35, no.1, pp.62-6, 2014

Erpolat, Ö. P. Et Al. (2014) . "Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: a national multi-center study.." European journal of gynaecological oncology , vol.35, no.1, pp.62-6.

@article{article, author={ÖZGE PETEK ERPOLAT Et Al. }, title={Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: a national multi-center study.}, journal={European journal of gynaecological oncology}, year=2014, pages={62-6} }